Courtney Breen
Stock Analyst at Bernstein
(0.36)
# 4,301
Out of 5,116 analysts
4
Total ratings
n/a
Success rate
-3.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Downgrades: Market Perform | $335 | $341.88 | -2.01% | 1 | Jan 20, 2026 | |
| LLY Eli Lilly and Company | Maintains: Outperform | $1,100 → $1,300 | $1,037.15 | +25.34% | 1 | Nov 24, 2025 | |
| MRNA Moderna | Initiates: Market Perform | $55 | $44.07 | +24.80% | 1 | Oct 17, 2024 | |
| PFE Pfizer | Initiates: Market Perform | $32 | $26.44 | +21.03% | 1 | Oct 17, 2024 |
Amgen
Jan 20, 2026
Downgrades: Market Perform
Price Target: $335
Current: $341.88
Upside: -2.01%
Eli Lilly and Company
Nov 24, 2025
Maintains: Outperform
Price Target: $1,100 → $1,300
Current: $1,037.15
Upside: +25.34%
Moderna
Oct 17, 2024
Initiates: Market Perform
Price Target: $55
Current: $44.07
Upside: +24.80%
Pfizer
Oct 17, 2024
Initiates: Market Perform
Price Target: $32
Current: $26.44
Upside: +21.03%